Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.775
+0.005 (0.28%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Sana Biotechnology Stock Forecast
SANA's stock price has decreased by -79.31% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Sana Biotechnology stock have an average target of 9.50, with a low estimate of 5.00 and a high estimate of 15. The average target predicts an increase of 435.21% from the current stock price of 1.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sana Biotechnology stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +519.72% | Apr 24, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +181.69% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +519.72% | Mar 18, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +294.37% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +519.72% | Jan 8, 2025 |
Financial Forecast
Revenue This Year
n/a
from 94.93M
Revenue Next Year
n/a
EPS This Year
-0.91
from -1.16
EPS Next Year
-0.87
from -0.91
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.65 | -0.63 | -0.56 | ||
| Avg | -0.91 | -0.87 | -0.85 | ||
| Low | -1.12 | -1.09 | -0.95 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.